Palo Alto, California, United States The leading representative office of defined VC is situated in the Palo Alto. The venture was found in North America in United States.
Among the most successful fund investment fields, there are Genetics, Biopharma. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Berkeley Lights, Lucira Health, Emboline. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Besides them, we counted 3 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Shangbay Capital, startups are often financed by Y Combinator, Medvance Incubator Partners, Data Collective DCVC. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, SV Tech Ventures, Aethan Capital. In the next rounds fund is usually obtained by WuXi Healthcare Ventures, Sequoia Capital China, Sangel Capital.
Related Funds
| Fund Name | Location |
| Decide4action | Greenville, South Carolina, United States |
| Digital Disrupt | - |
| GMH Ventures | Newtown Square, Pennsylvania, United States |
| Guosheng Financial Holding Inc | China, Foshan, Guangdong |
| Haitong Kaiyuan Investment | China, Shanghai |
| Hersh Interactive Group | - |
| Korea Credit Guarantee Fund | Daegu, South Korea, Taegu-jikhalsi |
| Loudwater Investment Partners | England, London, United Kingdom |
| Mechanics Bank | California, Richmond, United States |
| Million Tons Capital | China, Shanghai |
| Mindset Ventures | Brazil, São Paulo, Sao Paulo |
| Ningbo Dianshangcheng Investment Development | China, Ningbo, Zhejiang |
| Patriot Capital Funding | Connecticut, United States, Westport |
| POD Holding | Boston, Massachusetts, United States |
| Ranwa Technologies Co. | - |
| SternAegis Ventures | New York, New York, United States |
| Taiwan Tech Arena | - |
| Venture One | New York, New York, United States |
| XFactor Ventures | Boston, Massachusetts, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Venova Medical | $30M | 04 Sep 2024 | Los Gatos, California, United States | ||
Avation Medical | $22M | 01 Feb 2024 | Columbus, Ohio, United States | ||
Laplace Interventional | $12M | 24 Jul 2023 | Plymouth, Minnesota, United States | ||
Luminopia | $16M | 27 Jun 2023 | Cambridge, Massachusetts, United States | ||
Presidio Medical | $72M | 26 Jun 2023 | South San Francisco, California, United States | ||
Solenic Medical | $5M | 20 Jun 2023 | College Station, Texas, United States | ||
Noah Medical | $150M | 19 Apr 2023 | San Carlos, California, United States | ||
Flare Therapeutics | $123M | 22 Mar 2023 | Cambridge, Massachusetts, United States | ||
Telesair | $22M | 10 Jan 2023 | Irvine, California, United States |
– Minnesota based Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, announced that it has closed on its Series A financing led by a non-disclosed major strategic investor along with a significant investment from ShangBay Capital, an early stage medical device investor as well as other investors.
– The $7.9M Series A financing round will fund Laplace Interventional towards achieving its preclinical milestones.
– The company also announced the addition of two Directors to its Board including William Dai, Founding Managing Partner at ShangBay Capital.
– Laplace Interventional’s device aims to offer an increase in life expectancy and an improvement to the quality of life to several patients worldwide diagnosed with Tricuspid Regurgitation (TR).
– Fluid Biotech Inc. from Calgary, AB, Canada closed a $4.7m seed funding round.
– The round was led by Metis Innovative of Miami and ShangBay Capital of Palo Alto, California, with participation from new investors UCeed Health Fund and UCeed Child Health and Wellness Fund from the University of Calgary, Thin Air Labs, Wharton Alumni Angels, Amino Capital, Bluesky Equities, ThresholdImpact and Alabaster Capital.
– The company intends to use the funds to engage contract manufacturers to initiate production, complete regulatory milestones, and plan for first-in-human implantation.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Venova Medical | $30M | 04 Sep 2024 | Los Gatos, California, United States | ||
Avation Medical | $22M | 01 Feb 2024 | Columbus, Ohio, United States | ||
Laplace Interventional | $12M | 24 Jul 2023 | Plymouth, Minnesota, United States | ||
Luminopia | $16M | 27 Jun 2023 | Cambridge, Massachusetts, United States | ||
Presidio Medical | $72M | 26 Jun 2023 | South San Francisco, California, United States | ||
Solenic Medical | $5M | 20 Jun 2023 | College Station, Texas, United States | ||
Noah Medical | $150M | 19 Apr 2023 | San Carlos, California, United States | ||
Flare Therapeutics | $123M | 22 Mar 2023 | Cambridge, Massachusetts, United States | ||
Telesair | $22M | 10 Jan 2023 | Irvine, California, United States |
